血管生成在子宫腺肌病相关异常子宫出血和低生育力中的作用:一项系统综述
该系统综述检索PubMed和Embase至2019年2月,纳入20篇临床研究,发现子宫腺肌病患者异位和在位内膜的微血管密度及促血管生成标志物表达较对照内膜增加,且血管性血友病因子和两个促血管生成标志物染色水平与异常子宫出血相关;未发现血管生成标志物与低生育力关系的研究,也无临床研究评价抗血管生成治疗对腺肌病相关异常子宫出血或低生育力的有效性。
要点
- 子宫腺肌病患者异位内膜微血管密度均显著增加,在位内膜在4项研究中显著增加。
- 异位内膜血管内皮生长因子表达在5项研究中显著高于对照内膜。
- 血管性血友病因子及核因子-κB核p65和组织因子染色水平与异常子宫出血相关。
核心结论
- 结果支持以下假说:与对照患者子宫内膜相比,子宫腺肌病患者子宫内膜存在血管生成增加。
- 血管生成增加可能导致血管脆弱和通透性增加,从而引起子宫腺肌病相关异常子宫出血,并可能引起低生育力。
- 作者认为这一关联尚未得到充分研究,结果鼓励未来研究探讨血管生成在子宫腺肌病及其相关异常子宫出血或低生育力病因学中的确切作用,以设计治愈性或预防性治疗策略。
研究设计与样本
- 系统综述,检索PubMed和Embase至2019年2月,主要检索限于在绝经前女性中进行的临床研究。
- 从1669条检索结果中纳入20篇文章,纳入关注子宫腺肌病患者子宫内膜血管生成标志物的原创研究。
- 排除未与对照患者比较或未在同行评议期刊发表的研究;另进行第二次检索探讨靶向血管生成的治疗潜力,包括临床前研究。
主要发现
- 7项研究通过CD31、CD34、血管性血友病因子或因子VIII抗体染色微血管定量评估平均血管密度,均报告异位内膜平均血管密度显著增加;6篇涉及在位内膜的文章中4篇报告在位内膜平均血管密度较对照内膜显著增加。
- 5篇文章显示异位内膜血管内皮生长因子表达显著高于对照内膜,3篇文章显示在位内膜血管内皮生长因子表达显著高于对照内膜。
- 异位内膜中α-平滑肌肌动蛋白、内皮糖蛋白、S100A13、波形蛋白、基质金属蛋白酶、核因子-κB、组织因子、DJ-1、磷酸化哺乳动物雷帕霉素靶蛋白、激活素A、卵泡抑素和肌肉生长抑制素、CD41、SLIT、Roundabout 1、环氧合酶-2、溶血磷脂酸1,4-5、磷酸化信号转导和转录激活因子3、白细胞介素-6、白细胞介素-22和转化生长因子-β1较对照内膜增加。
- 在位内膜中S100A13、基质金属蛋白酶-2和-9、组织因子、卵泡抑素、肌肉生长抑制素、Roundabout 1、溶血磷脂酸1和4-5、磷酸化信号转导和转录激活因子3、白细胞介素-6和白细胞介素-22较对照内膜增加;异位内膜中E-钙黏蛋白、真核翻译起始因子3亚基和视黄酸-干扰素诱导死亡19相关基因较对照内膜降低,在位内膜中白细胞介素-10较对照内膜降低。
- 血管性血友病因子和两个促血管生成标志物(核因子-κB核p65和组织因子)的染色水平与子宫腺肌病患者异常子宫出血相关;未发现研究探讨血管生成标志物与子宫腺肌病患者低生育力之间的可能关系。
临床怎么用
- 9篇文章报告了直接或间接靶向子宫腺肌病血管生成的研究,包括在临床研究中测试激素治疗或草药化合物,或在临床前研究中测试血管生成抑制剂。
- 尚无临床研究评价此类治疗对子宫腺肌病相关异常子宫出血或低生育力的有效性。
局限性
- 未发现研究探讨血管生成标志物与子宫腺肌病患者低生育力之间的可能关系。
- 尚无临床研究评价靶向血管生成治疗对子宫腺肌病相关异常子宫出血或低生育力的有效性。
- 作者认为血管生成增加与子宫腺肌病相关异常子宫出血及可能低生育力的关联尚未得到充分研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adenomyosis commonly occurs with abnormal uterine bleeding (AUB) and is associated with subfertility and a higher miscarriage rate. Recent evidence showed abnormal vascularization in the endometrium in patients with adenomyosis, suggesting a role of angiogenesis in the pathophysiology of AUB and subfertility in adenomyosis and providing a possible treatment target. OBJECTIVE AND RATIONALE: We hypothesized that the level of abnormal vascularization and expression of angiogenic markers is increased in the ectopic and eutopic endometrium of adenomyosis patients in comparison with the endometrium of control patients. This was investigated through a search of the literature. SEARCH METHODS: A systematic search was performed in PubMed and Embase until February 2019. Combinations of terms for angiogenesis and adenomyosis were applied as well as AUB, subfertility or anti-angiogenic therapy. The main search was limited to clinical studies carried out on premenopausal women. Original research articles focusing on markers of angiogenesis in the endometrium of patients with adenomyosis were included. Studies in which no comparison was made to control patients or which were not published in a peer-reviewed journal were excluded. A second search was performed to explore the therapeutic potential of targeting angiogenesis in adenomyosis. This search also included preclinical studies. OUTCOMES: A total of 20 articles out of 1669 hits met our selection criteria. The mean vascular density (MVD) was studied by quantification of CD31, CD34, von Willebrand Factor (vWF) or factor-VIII-antibody-stained microvessels in seven studies. All these studies reported a significantly increased MVD in ectopic endometrium, and out of the six articles that took it into account, four studies reported a significantly increased MVD in eutopic endometrium compared with control endometrium. Five articles showed a significantly higher vascular endothelial growth factor expression in ectopic endometrium and three articles in eutopic endometrium compared with control endometrium. The vascular and pro-angiogenic markers α-smooth muscle actin, endoglin, S100A13, vimentin, matrix metalloproteinases (MMPs), nuclear factor (NF)-kB, tissue factor (TF), DJ-1, phosphorylated mammalian target of rapamycin, activin A, folli- and myostatin, CD41, SLIT, roundabout 1 (ROBO1), cyclooxygenase-2, lysophosphatidic acid (LPA) 1,4-5, phospho signal transducer and activator of transcription 3 (pSTAT3), interleukin (IL)-6, IL-22 and transforming growth factor-β1 were increased in ectopic endometrium, and the markers S100A13, MMP-2 and -9, TF, follistatin, myostatin, ROBO1, LPA1 and 4-5, pSTAT3, IL-6 and IL-22 were increased in eutopic endometrium, compared with control endometrium. The anti-angiogenic markers E-cadherin, eukaryotic translation initiation factor 3 subunit and gene associated with retinoic-interferon-induced mortality 19 were decreased in ectopic endometrium and IL-10 in eutopic endometrium, compared with control endometrium. The staining level of vWF and two pro-angiogenic markers (NF-κB nuclear p65 and TF) correlated with AUB in patients with adenomyosis. We found no studies that investigated the possible relationship between markers of angiogenesis and subfertility in adenomyosis patients. Nine articles reported on direct or indirect targeting of angiogenesis in adenomyosis-either by testing hormonal therapy or herbal compounds in clinical studies or by testing angiogenesis inhibitors in preclinical studies. However, there are no clinical studies on the effectiveness of such therapy for adenomyosis-related AUB or subfertility. WIDER IMPLICATIONS: The results are in agreement with our hypothesis that increased angiogenesis is present in the endometrium of patients with adenomyosis compared with the endometrium of control patients. It is likely that increased angiogenesis leads to fragile and more permeable vessels resulting in adenomyosis-related AUB and possibly subfertility. While this association has not sufficiently been studied yet, our results encourage future studies to investigate the exact role of angiogenesis in the etiology of adenomyosis and related AUB or subfertility in women with adenomyosis in order to design curative or preventive therapeutic strategies.
引用
- Harmsen MJ, Wong CFC, Mijatovic V, et al. Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review. Hum Reprod Update. 2019. PMID: 31504506. doi:10.1093/humupd/dmz024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。